By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NanoString Technologies Inc. 

201 Elliott Avenue West
Suite 300
Seattle  Washington  98119  U.S.A.
Phone: 206-378-NANO Fax: 206-378-6288



Company News
NanoString (NSTG) Expands Immuno-Oncology Portfolio With Commercial Launch Of Innovative Ncounter RNA:Protein Pancancer Immune Profiling Panel 9/11/2015 7:06:33 AM
NanoString (NSTG) To Unveil Strategic Roadmap For Growth And Market Expansion 9/11/2015 6:58:58 AM
NanoString (NSTG) Release: ESMO Clinical Practice Guidelines For Breast Cancer Recommend The Use Of Prosigna/PAM50 Assay For Determining Potential Benefit From Chemotherapy 9/9/2015 7:50:59 AM
NanoString (NSTG) To Present At Upcoming Investor Conferences 8/27/2015 7:14:44 AM
NanoString (NSTG) Receives Favorable Final Local Coverage Determination By Palmetto GBA For Its Prosigna Breast Cancer Assay 8/14/2015 7:56:51 AM
NanoString (NSTG) Releases Financial Results For Second Quarter Of 2015 8/5/2015 1:41:36 PM
Seattle Biotech NanoString (NSTG)'s Revenue Up 20% as Company Shifts Focus to Cancer Diagnostics 8/5/2015 6:00:54 AM
NanoString (NSTG) To Present At The Canaccord Genuity Growth Conference 7/31/2015 7:31:48 AM
NanoString (NSTG) CEO On How Creating A Niche Is Good For Business: Q&A 7/23/2015 7:30:08 AM
NanoString (NSTG) To Release Second Quarter 2015 Financial Results And Host Conference Call On Tuesday, August 4, 2015 7/22/2015 7:42:26 AM